Portfolio company
AcousticaBio
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops fluid processing technology to formulate medicines into high-concentration subcutaneous injections for biopharmaceutical firms and healthcare providers.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Elektrofi
The company develops a microparticle technology platform that enables subcutaneous self-administration of high-concentration biologic medicines for biopharmaceutical firms and their patients.
Surf Bio
This company develops drug stabilisation and delivery platforms for pharmaceutical manufacturers to enable high-concentration subcutaneous administration of biologics and vaccines.
SonoThera™
This company develops an ultrasound-guided non-viral platform to deliver genetic medicines for patients with chronic and rare diseases.
Precision Microbubbles
The company produces a microfluidic device that sorts microbubbles into uniform sizes for medical researchers, pharmaceutical teams and ultrasound contrast agent manufacturers.
Active Needle
This company develops ultrasonic needle actuation devices for clinicians to improve visibility and precision during ultrasound-guided interventional procedures such as biopsies and drug delivery.
Biothrust
This company develops bionic bioreactors for bubble-free cell cultivation to enable scalable manufacturing for pharmaceutical firms, research institutions and therapy developers.
Eco-Inject
The company manufactures bio-based, single-use autoinjector devices for pharmaceutical and biotechnology firms to deliver injectable therapies with a reduced carbon footprint.
Disruptive Pharma
This company develops a drug formulation platform to improve the solubility and bioavailability of pharmaceutical compounds for the healthcare industry.
